PHASEBIO PHARMACEUTICALS INC - COM (PHASQ)

CUSIP: 717224109

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / COM
Total 13F shares
557,722
Share change
-21,571,337
Total reported value
$15,552
Price per share
$0.03
Number of holders
4
Value change
-$3,799,000
Number of buys
1
Number of sells
22

Quarterly Holders Quick Answers

What is CUSIP 717224109?
CUSIP 717224109 identifies PHASQ - PHASEBIO PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PHASEBIO PHARMACEUTICALS INC - COM (PHASQ) as of Q4 2022

As of 31 Dec 2022, PHASEBIO PHARMACEUTICALS INC - COM (PHASQ) was held by 4 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 557,722 shares. The largest 4 holders included DAFNA Capital Management LLC, ACADIAN ASSET MANAGEMENT LLC, HAMILTON LANE ADVISORS LLC, and IPG Investment Advisors LLC. This page lists 4 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.